The role of the cardiovascular specialist in the prevention of cardiovascular diseases - Executive summary

Canadian Journal of Cardiology

Volumn 15, Issue SUPPL. G, 1999, Pages

  Collins Nakai, Ruth L ^a   Dagenais, Gilles R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANADA; CARDIOLOGY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; FEMALE; HEALTH EDUCATION; HUMAN; MALE; MEDICAL PROFESSION; MIDDLE AGED; MORTALITY; PATIENT CARE; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; CANADA; CARDIOLOGY; CARDIOVASCULAR DISEASES; FEMALE; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; PATIENT CARE TEAM; RISK FACTORS; SPECIALISM; SURVIVAL RATE;

EID: 0033252884     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Canadian Heart Health Surveys: A profile of cardiovascular risk. Can Med Assoc J 1992;146:1969-2029.
2. Sackett DL. Rules of evidence and clinical recommendations for the use of antithrombotic agents. Chest 1986;89:25-36.
3. Pyorala K, De Bacher G, Graham I, et al. Prevention of coronary heart disease in clinical practice. Recommendation of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur J Cardiol 1994;15:1300-31.
4. Fuster V, Pearson TA, Abrams J, et al. The 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events. J Am Coll Cardiol 1996;27:957-1047.
5. Mosca L, Judelson MD, King K, et al. AHA/ACC Medical/Scientific Statement Consensus Panel Statement: A guide to preventive cardiology for women. J Am Coll Cardiol 1999;99:1751-3.
6. HOPE investigators. Effects of an angiotensin converting enzyme inhibitor, rampiril, on death from cardiovascular causes, myocardial infarction and stroke in high risk patients. N Engl J Med. (In press)